Lv1
30 积分 2025-08-13 加入
Efficacy and safety of fezolinetant and elinzanetant for vasomotor symptoms in postmenopausal women: A systematic review and meta-analysis
3天前
已完结
Fezolinetant: First Approval
6天前
已完结
Management of perimenopausal and menopausal symptoms
9天前
已完结
Fezolinetant and Elinzanetant Therapy for Menopausal Women Experiencing Vasomotor Symptoms
9天前
已完结
Factor D
11天前
已完结
Danicopan: First Approval
11天前
已完结
Complement factor D is a drug target for metabolic-associated fatty liver disease
15天前
已完结
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
16天前
已完结
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
16天前
已完结
The complement system: Biology, pathology, and therapeutic interventions
19天前
已完结
Indirect Effect Model with Surge-Function for Describing Melatonin Circadian Rhythm: Quantitative Comparison and Application Between Normal Sleepers and Patients with Delayed Sleep-Wake Phase Disorder
皖公网安备34019202002308
